NCT01211821View on ClinicalTrials.gov

Effect of BMS-914392 on Pharmacokinetics of Metoprolol

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Atrial Fibrillation
Interventions
DRUG

metoprolol

Tablets, Oral, 200 mg, once, 1 day

DRUG

BMS-914392

Tablets, Oral, 60 mg, once daily, 7 days

Trial Locations (1)

66219

Pra International, Lenexa

Sponsors

Collaborators (1)

PRA Health Sciences
All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT01211821 - Effect of BMS-914392 on Pharmacokinetics of Metoprolol | Biotech Hunter | Biotech Hunter